Horizon Cancer Mission: Virtual Human Twins
Funds up to four €8-9M grants for teams building AI-driven digital models of a patient's cancer to predict how it develops and guide personalised treatment.
Cancer research usually works from broad patterns across many patients. That approach struggles hardest on the cancers this topic targets: ones with few treatment options, biology that is not well understood, low five-year survival, or cancers that appear early in life. This topic funds a different tool — a computer model built from one patient's own data, detailed enough to help predict how their…
Building and testing multiscale virtual human twins — AI-driven digital models of a patient's own cancer biology, from cells and tissues up to organs — to understand how a cancer starts and develops, and to personalise treatment. Priority goes to cancers with few treatment options or unclear biology: refractory cancers, rare cancers, early-onset cancers, cancers with low five-year survival, and paediatric or adolescent cancers. Models are validated against real patient data — new or existing, multi-omics, imaging, and real-world data — with age, sex and gender differences built into the modelling itself. Results are published as FAIR data and made available through the UNCAN.eu and Advanced Virtual Human Twin platforms.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up